Abstract

In the presence of galactose, lithium ions activate the unfolded protein response (UPR) by inhibiting phosphoglucomutase activity and causing the accumulation of galactose-related metabolites, including galactose-1-phosphate. These metabolites also accumulate in humans who have the disease classic galactosemia. Here, we demonstrate that Saccharomyces cerevisiae yeast strains harboring a deletion of UBX4, a gene encoding a partner of Cdc48p in the endoplasmic reticulum-associated degradation (ERAD) pathway, exhibit delayed UPR activation after lithium and galactose exposure because the deletion decreases galactose-1-phosphate levels. The delay in UPR activation did not occur in yeast strains in which key ERAD or proteasomal pathway genes had been disrupted, indicating that the ubx4Δ phenotype is ERAD-independent. We also observed that the ubx4Δ strain displays decreased oxygen consumption. The inhibition of mitochondrial respiration was sufficient to diminish galactose-1-phosphate levels and, consequently, affects UPR activation. Finally, we show that the deletion of the AMP-activated protein kinase ortholog-encoding gene SNF1 can restore the oxygen consumption rate in ubx4Δ strain, thereby reestablishing galactose metabolism, UPR activation, and cellular adaption to lithium-galactose challenge. Our results indicate a role for Ubx4p in yeast mitochondrial function and highlight that mitochondrial and endoplasmic reticulum functions are intertwined through galactose metabolism. These findings also shed new light on the mechanisms of lithium action and on the pathophysiology of galactosemia.

Highlights

  • In the presence of galactose, lithium ions activate the unfolded protein response (UPR) by inhibiting phosphoglucomutase activity and causing the accumulation of galactoserelated metabolites, including galactose-1-phosphate

  • Yeast cells treated with lithium in the presence of galactose exhibit modifications in cellular homeostasis such as changes in glycogen, calcium, and phosphate levels and a metabolic shift from fermentation to respiration [3, 9,10,11]

  • Based on a genetic screen to identify new regulators of UPR activation induced by lithium and galactose treatment, we identified that the deletion of the UBX4/YMR067C gene delays UPR activation (Fig. 1A)

Read more

Summary

ARTICLE cro

Machado‡, Silas Pinto§, Antonio Galina¶, Marcelo A. Mori§, Monica Montero-Lomeli‡, and X Claudio A. Masuda‡2 From the ‡Programa de Biologia Molecular e Biotecnologia and the ¶Programa de Bioquımica e Biofısica Celular, Instituto de Bioquımica Medica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil and the §Department of Biochemistry and Tissue Biology, Instituto de Biologia, Universidade Estadual de Campinas, Campinas SP, 13083-970, Brazil

Edited by Ursula Jakob
Results
Discussion
YPGal YPGal YPGal YPGal YPGal YPGal
Yeast strains and growth conditions
Plate growth assay
Respiration rate in vivo
Respiration rate in vitro
Statistical analysis

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.